Vaccinex Inc. (VCNX) |
|
5.64 -0.5 (-8.14%)
|
02-14 16:00 |
|
Open: |
5.89 |
Pre. Close: |
6.14 |
|
High:
|
5.89 |
Low:
|
5.42 |
|
Volume:
|
21,048 |
Market Cap:
|
95M |
|
|
|
|
Vaccinex, Inc., a clinical-stage biotechnology company, discovers and develops bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab that is in clinical development stage for the treatment of non-small cell lung cancer (NSCLC), osteosarcoma, melanoma, and Huntington's disease. The company is also developing VX5, a human antibody to CXCL13 that is in preclinical development for the treatment of MS and potentially for other autoimmune disorders; VX25, a bi-specific natural killer T (NKT) cell stimulator, for the therapeutic application of NKT cell stimulation for cancer immunotherapy; BVX20, an investigational and humanized monoclonal antibody for the treatment of for multiple sclerosis. It has a clinical trial collaboration and supply agreement with Merck KGaA to test pepinemab in combination with avelumab checkpoint inhibitor in NSCLC p |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
5.899 - 5.94 |
5.94 - 5.972 |
|
Low:
|
5.318 - 5.371 |
5.371 - 5.411 |
|
Close:
|
5.565 - 5.638 |
5.638 - 5.695 |
|
Technical analysis |
as of: 2020-02-14 4:33:30 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 11.01 One year: 14.28 |
| Support: |
Support1: 4.88 Support2: 4.06 |
| Resistance: |
Resistance1: 9.42 Resistance2: 12.23 |
| Pivot: |
6.74  |
| Moving Average: |
MA(5): 6.21 MA(20): 6.43 
MA(100): 5.68 MA(250): 5.59 |
| MACD: |
MACD(12,26): 0.15 Signal(9): 0.31 |
| Stochastic oscillator: |
%K(14,3): 10.93 %D(3): 15.80 |
| RSI: |
RSI(14): 44.11 |
| 52-week: |
High: 12.23 Low: 3.77 Change(%): 23.1 |
| Average Vol(K): |
3-Month: 2482 10-Days: 2481 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.VCNX has closed above bottom band by 9.1%. Bollinger Bands are 38.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2020-01-28
The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 27) 10X Genomics Inc (NASDAQ: TXG ) Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN )(announced early termination of waiting period for its proposed acquisition by Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN )) Cidara Therapeutics Inc (NASDAQ: CDTX ) Cleveland BioLabs, Inc. (NASDAQ: CBLI )(saw a coronavirus-induced rally ) Denali Therapeutics Inc (NASDAQ: DNLI ) Dr.Reddy's Laboratories Ltd (NYSE: RDY )(reacted to its Q3 results) Inovio Pharmaceuticals Inc (NASDAQ: INO )(announced Nevro Corp (NYSE: NVRO ) Oyster Point Pharma Inc (NASDAQ: OYST ) Quest Diagnostics Inc (NYSE: DGX ) Rapt Therapeutics Inc (NASDAQ: RAPT ) SI-Bone Inc (NASDAQ: SIBN ) Vaccinex Inc (NASDAQ: VCNX ) Vir Biotechnology Inc (NASDAQ: VIR ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Jan. 27) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) Axovant Gene Therapies Ltd (NASDAQ: AXGT ) Avanos Medical Inc (NYSE: AVNS ) Blueprint Medicines Corp (NASDAQ: BPMC ) Correvio Pharma Corp (NASDAQ: CORV ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Heat Biologics Inc (NASDAQ: HTBX ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Kura Oncology Inc (NASDAQ: KURA ) Madrigal Pharmaceuticals Inc (NASDAQ: MDGL ) MediciNova, Inc.
2019-08-14
Vaccinex (VCNX) Attains Full Enrollment in Lung Cancer Study
Vaccinex (VCNX) completes enrollment in a phase Ib/II study of its pipeline candidate pepinemab in combination with Bavencio for treating advanced non-small cell lung cancer.
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NasdaqCM |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
14.86 |
| Shares Float (M) |
3.05 |
|
% Held by Insiders
|
25.48 |
|
% Held by Institutions
|
58.77 |
|
Shares Short (K)
|
69 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-2.820 |
|
Book Value (p.s.)
|
-1.350 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-4775.04 |
|
Return on Assets (ttm)
|
-105.2 |
|
Return on Equity (ttm)
|
-245.8 |
|
Qtrly Rev. Growth
|
104.0 |
|
Gross Profit (p.s.)
|
-0.021 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-2.288 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-32.47 |
|
Levered Free Cash Flow (M)
|
-20.06 |
Stock Valuations |
|
P/E
|
-2.00 |
|
P/E Growth Ratio
|
-0.05 |
|
P/BV
|
-4.18 |
|
P/S
|
94.00 |
|
P/CF
|
-2.58 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
